Cmax is out of the range [Study As­sess­ment]

posted by jag009  – NJ, 2018-08-02 17:56  – Posting: # 19128
Views: 1,706

Hi,

» We recently conducted a BE trial. It was a classical 2-period, 2-sequence study of a drug that consists of a combination of two active substances. Unfortunately, results one of analytes, a parent drug, fell sightly outside of the 80-125% range, below 80% for Cmax. CV was below 30% and post-hoc power was less than 80% for this analyte...

Sorry, there is no way for you to argue.
John

Complete thread:

Activity
 Admin contact
20,122 posts in 4,245 threads, 1,383 registered users;
online 26 (1 registered, 25 guests [including 11 identified bots]).
Forum time (Europe/Vienna): 13:29 CET

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5